Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRN | P28799 | 1/20 | 0.36 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | BHMT | Q93088 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9290922 | 0.89 | TET2 (0.39) | GRNSORT1TET2TET3TET1 | |
| SCHEMBL2294818 | 0.89 | TDP1 (0.35) | GRNSORT1TDP1ALDH1A1 | |
| SCHEMBL4443797 | 0.80 | TET2 (0.54) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL4623050 | 0.78 | TDP1 (0.35) | GRIK1TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL8909192 | 0.78 | TDP1 (0.48) | TDP1ALDH1A1SMN1; SMN2BHMT | |
| SCHEMBL11309347 | 0.78 | TDP1 (0.48) | GRIK1TDP1ALDH1A1SMN1; SMN2 | |
| SCHEMBL2045388 | 0.78 | TDP1 (0.48) | TDP1ALDH1A1SMN1; SMN2BHMT | |
| SCHEMBL4144659 | 0.77 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL3136053 | 0.77 | MME (0.39) | GRNSORT1TET2TET3TET1 | |
| SCHEMBL31198158 | 0.76 | TDP1 (0.42) | GRNSORT1TET2TET3TET1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| EP-0178532-B1 | PERFUMING COMPOSITIONS AND PERFUMED ARTICLES CONTAINING ETHYL-2-ACETYL-4-METHYL-4-PENTENOATE | FIRMENICH SA (CH) | 1990-06-06 | — | — | EP | claimed |
| EP-0178532-A2 | Perfuming compositions and perfumed articles containing ethyl-2-acetyl-4-methyl-4-pentenoate | FIRMENICH SA (CH) | 1986-04-23 | — | — | EP | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12024690-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor accord comprising 4-(dodecylthio)-4-methylpentan-2-one | GIVAUDAN SA (CH) | 2024-07-02 | — | — | US | disclosed |
| US-12018226-B2 | Perfuming compositions | FIRMENICH SA (CH) | 2024-06-25 | — | — | US | disclosed |
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | disclosed |
| US-20220002637-A1 | A METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | GIVAUDAN S.A. (CH) | 2022-01-06 | — | — | US | disclosed |
| EP-3898912-A1 | A METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | Givaudan SA (CH) | 2021-10-27 | — | — | EP | disclosed |
| US-11117860-B2 | Phenyl urea derivatives as n-formyl peptide receptor modulators | ALLERGAN, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| EP-1951244-A2 | CALCILYTIC COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007062370-A2 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-0405427-B1 | Aromatic compounds, process for their preparation and their use as perfuming ingredients | FIRMENICH & CIE (CH) | 1995-03-29 | — | — | EP | disclosed |
| EP-0178532-B1 | PERFUMING COMPOSITIONS AND PERFUMED ARTICLES CONTAINING ETHYL-2-ACETYL-4-METHYL-4-PENTENOATE | FIRMENICH SA (CH) | 1990-06-06 | — | — | EP | disclosed |
| EP-0178532-B1 | PERFUMING COMPOSITIONS AND PERFUMED ARTICLES CONTAINING ETHYL-2-ACETYL-4-METHYL-4-PENTENOATE | FIRMENICH SA (CH) | 1990-06-06 | — | — | EP | disclosed |
| EP-0178532-A2 | Perfuming compositions and perfumed articles containing ethyl-2-acetyl-4-methyl-4-pentenoate | FIRMENICH SA (CH) | 1986-04-23 | — | — | EP | disclosed |
| EP-0178532-A2 | Perfuming compositions and perfumed articles containing ethyl-2-acetyl-4-methyl-4-pentenoate | FIRMENICH SA (CH) | 1986-04-23 | — | — | EP | disclosed |
| EP-0178532-A2 | Perfuming compositions and perfumed articles containing ethyl-2-acetyl-4-methyl-4-pentenoate | FIRMENICH SA (CH) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117860-B2 | Phenyl urea derivatives as n-formyl peptide receptor modulators | FPR1, FPR2, FPR3 | GRN 817/4885SORT1 2771/4885TET2 4875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.